tbuckley/cabot-search huggingface dataset:
Erratum
Journal: JNCI Journal of the National Cancer Institute (1995)

“Estrogen Metabolism and Excretion in Oriental and Caucasian Women,” by H. Adlercreutz et al. [J Natl Cancer Inst 86:1076-1082, 1994 (Issue 14)]. The right side of the original Fig. 1 was inadvertently cut off ( see new Fig. 1, right). The authors regret the error.
Driving and Alzheimer Disease
Authors: Jeffrey A. Mattes
Journal: JAMA (1996)

<h3>To the Editor.</h3> —In the article by Dr Fitten and colleagues<sup>1</sup>regarding Alzheimer disease and driving, do the authors have data on what type of crashes and moving violations these patients were involved in? My impression is that many Alzheimer patients can drive reasonably well if their spouse is in the car giving necessary directions and advice. In an effort to allow patients to drive as long as possible (especially if only one member of an elderly couple drives and that person develops Alzheimer disease), it might be reasonable to evaluate driving ability of the two as a pair, with the spouse assisting the patient as he or she normally does.
Abstract 012: Psoriasis is Associated With Atherogenic Lipoprotein Particle Concentration and Size Independent of Cardiometabolic Risk Factors
Authors: Ron C Li, Parasuram Krishnamoorthy, YiDing Yu, Jules Antigua, Anna Raper, Amanda Baer, Stephanie Derohannessian, Mackenzie Wilcox, Abby S Van Vorohees, Joel M Gelfand, Nehal N Mehta
Journal: Circulation (2012)

Introduction: Psoriasis is a chronic inflammatory skin disease associated with increased risk of cardiovascular disease (CVD). We have previously shown that psoriasis is associated with atherogenic lipoprotein particle concentration and size. However, it is unknown whether this association is independent of traditional CVD risk factors or insulin resistance (IR). Methods: We prospectively enrolled a consecutive sample of patients with psoriasis (n=122) and compared cardiometabolic risk factors with an asymptomatic sample without psoriasis from our practice (n=129). Fasting lipids, insulin, glucose were measured by standard assays, and lipoprotein concentration and size were measured by nuclear magnetic resonance (NMR) (LipoScience, North Carolina). HOMA-IR, an estimation of IR, was calculated by standard methods. Multivariable linear regression for adjusted models was performed using STATA12 software. Results: LDL-C and HDL-C were lower in psoriasis compared to controls [106.9 mg/dL (90-132.5) vs 128 (110.2-145.6), p&lt;0.01 and 43 mg/dL (36-58) vs 50 (42-62), p&lt;0.01] with no difference in triglycerides. However, NMR showed an atherogenic profile in psoriasis similar to that observed in diabetes, with significant increase in LDL [1210.5 (1002-1498) vs 1115 (935-1291), p=0.03] particle concentration with a concomitant decrease in LDL size [20.6 (20.3-21.1) vs 21.3 (20.6-21.1), p&lt;0.001] even after adjusting for obesity, tobacco use, hypertension, lipids, and HOMA-IR (p=0.001). An increase in VLDL particle concentration was also seen before [61.9 (38.3-95.3) vs 53.4 (30.4-84.5), p=0.05] and after adjusting for cardiometabolic risk factors (p=0.018). Conclusions: Despite normal lipids, we demonstrate a more atherogenic lipoprotein profile by NMR in psoriasis compared to healthy controls after adjustment for CVD risk factors and IR. These findings suggest that traditional risk factor analysis and lipid testing may not ideally capture the increased CVD risk observed in psoriasis.
Derivation and maturation of synthetic and contractile vascular smooth muscle cells from human pluripotent stem cells
Authors: Maureen Wanjare, Frederick Kuo, Sharon Gerecht
Journal: Cardiovascular Research (2012)

AimsEmbryonic vascular smooth muscle cells (vSMCs) have a synthetic phenotype; in adults, they commit to the mature contractile phenotype. Research shows that human pluripotent stem cells (hPSCs) differentiate into vSMCs, but nobody has yet documented their maturation into the synthetic or contractile phenotypes. This study sought to control the fate decisions of hPSC derivatives to guide their maturation towards a desired phenotype.
Speculation on future use of blood or blood component therapy
Authors: I. Davidsohn
Journal: JAMA (1967)

In<i>The American College Dictionary</i>there are six definitions of "speculation." According to the one best applicable to our topic, "speculation" means conjectural consideration of a matter. "Conjecture" is defined as expression of an opinion without sufficient evidence for proof. If I add to this definition the circumstance that the subject of this communication was assigned to me, then I could permit my imagination to roam as freely as that of a science-fiction writer and not be shackled by lack of supporting facts or by my own ignorance—of which, in this particular assignment, I have an abundant supply. However, tempted as I am, it is impossible to speculate so freely within the available space. This limitation and a respect for my audience have made me choose another approach, namely, the projecting into the future of the early attempts at blood therapy, even though these attempts have been, at least for
SPENCER AND POPULAR BIOLOGY.
Journal: JAMA (1903)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
MINUTES OF THE AMERICAN MEDICAL ASSOCIATION AT ITS 34TH ANNUAL SESSION, HELD IN CLEVELAND, OHIO, JUNE 5, 6, 7, 8, 1883.
Journal: JAMA (1883)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Pump and circumstance
Journal: JAMA (1971)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Linkage Between Axonal Ensheathment and Basal Lamina Production by Schwann Cells
Authors: R. Bunge
Journal: Annual Review of Neuroscience (1986)

The brain's default mode network consists of discrete, bilateral and symmetrical cortical areas, in the medial and lateral parietal, medial prefrontal, and medial and lateral temporal cortices of the human, nonhuman primate, cat, and rodent brains. Its ...Read More
Highlights
Journal: JAMA Internal Medicine (2019)

In this randomized clinical trial of 602 overweight and obese adults from 40 states across the United States, Patel and colleagues assessed the effectiveness of support, collaboration, and competition within a behaviorally designed gamification intervention to increase physical activity.Participants used a wearable device to track daily steps, established a baseline, selected a step goal increase, were randomly assigned to a control or to 1 of 3 gamification interventions, and were remotely monitored.Results showed that the gamification arm had the greatest increase in physical activity from baseline during the intervention; during the 12-week follow-up, physical activity was lower among the cohort but remained greater in the gamification arm.
SECOND ANNUAL REPORT OF THE HARVARD CANCER COMMITTEE.
Journal: JAMA (1902)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
PRECOCIOUS MENSTRUATION
Authors: F. P. GENGENBACH
Journal: JAMA (1913)

The term "precocious menstruation" should be limited to cases of more or less periodical menstrual discharge occurring in children before its usual appearance at the age of puberty (before the age of 9 or 10 years—Schauta), and should not include cases of hemorrhage from the vagina occurring within a few days after birth and not recurring subsequently. Precocious menstruation is usually accompanied by signs of precocious maturity, i. e., "the premature development of the whole organism concurrently with menstruation and ovulation" (Morse<sup>1</sup>); or, in other words. "precocious menstruation with an early appearance of the external manifestations of puberty" (Croom<sup>2</sup>). These cases are by far the most interesting, and my case is of that type. <h3>REPORT OF CASE</h3> <i>History</i>.—Baby X., ugod at time of examination 2 years (January, 1913). Adopted shortly after birth, at which time a Wassermann proved negative. History of parents unobtainable except that father
Paclitaxel, ifosfamide, and cisplatin (TIP) salvage therapy for patients (pts) with relapsed testicular germ cell tumors (GCT)
Authors: J. Mardiak, T. Salek, Z. Sycova-Mila, Z. Hlavata, J. Obertova, M. Mego, M. Reckova, I. Koza
Journal: Journal of Clinical Oncology (2004)

4632
Seventh International Conference on Defined Immunofluorescence, Immunoenzyme Studies, and Related Labeling Techniques
Journal: JNCI Journal of the National Cancer Institute (1981)

Journal Article Seventh International Conference on Defined Immunofluorescence, Immunoenzyme Studies, and Related Labeling Techniques Get access JNCI: Journal of the National Cancer Institute, Volume 67, Issue 4, October 1981, Page 957, https://doi.org/10.1093/jnci/67.4.957-d Published: 01 October 1981
BUENOS AIRES
Journal: JAMA (1922)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Malnutrition and the Eye.
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
RECORDING OF EUROPEAN SOCIETY OF GASTROINTESTINAL ENDOSCOPY (ESGE) PERFORMANCE MEASURES: OBSERVATIONS FROM THE EUROPEAN COLONOSCOPY QUALITY INVESTIGATION (ECQI) QUESTIONNAIRE
Authors: E Toth, A Agrawal, P Amaro, L Brink, W Fischbach, M Hünger, R Jover, U Kinnunen, A Koulaouzidis, A Ono, Á Patai, S Pecere, L Petruzziello, JF Riemann, B Amlani, C Spada
Journal: Endoscopy (2019)

To investigate how selected ESGE performance measures are assessed in current clinical practice, using online questionnaires.
Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis*1
Authors: A LUCA
Journal: Hepatology (1995)

The study investigated the hemodynamic and neurohumoral effects of albumin infusion after total paracentesis in 18 patients with cirrhosis and tense ascites. Measurements of systemic and splanchnic hemodynamics, and vasoactive neurohumoral systems were performed before and immediately after total paracentesis. The patients were then randomized to receive albumin or not, and hemodynamic and humoral measurements were repeated at 24 hours. Hemodynamic and humoral changes just after paracentesis were similar in patients later randomized to receive albumin infusion or not. Twenty-four hours after total paracentesis, patients not receiving albumin had significant reductions in cardiac index (−13%; P = .005), femoral blood flow (−17%; P = .004), and pulmonary capillary pressure (−16%; P = .02), which were accompanied by significant increases in plasma renin activity (PRA) and plasma aldosterone (PA) and by significant decreases in atrial natriuretic factor (ANF) and plasma sodium. By contrast, there were no significant changes in patients receiving albumin, except for an increase in ANF and a further decrease in PA. In both groups, hepatic venous pressure gradient (HVPG) and azygos blood flow decreased just after paracentesis returning to baseline at 24 hours. This study shows that albumin infusion prevents the impairment in systemic hemodynamics, vasoactive neurohumoral systems, and plasma sodium after a large-volume paracentesis, without detrimental effects on portal pressure and portocollateral blood flow.
Cell Count, Viral Load, and Clinical Outcome in Patients with HIV Infection after Highly Active Antiretroviral Therapy
Journal: Annals of Internal Medicine (2000)

Summaries for Patients19 September 2000Cell Count, Viral Load, and Clinical Outcome in Patients with HIV Infection after Highly Active Antiretroviral TherapySearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-133-6-200009190-00001 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail What is the problem and what is known about it so far?A combination of powerful anti-HIV drugs known as highly active antiretroviral therapy (HAART) can prevent AIDS-related complications in persons with HIV infection. Two laboratory tests, CD4 cell count and viral load, are used to monitor patients' response to HAART. CD4 count is a measure of immune cells; high CD4 counts are better than low ones. The viral load test directly measures the amount of the virus in a person's blood; the lower the viral load, the better. It is not known which test is better at predicting how ... Author, Article, and Disclosure InformationAffiliations: The summary below is from the full report titled “Clinical Outcome of Patients with HIV-1 Infection according to Immunologic and Virologic Response after 6 Months of Highly Active Antiretroviral Therapy.” It is in the 19 September 2000 issue of Annals of Internal Medicine (volume 133, pages 401-410). The authors are S Grabar, V Le Moing, C Goujard, C Leport, MD Kazatchkine, D Costagliola, and L Weiss.Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoClinical Outcome of Patients with HIV-1 Infection according to Immunologic and Virologic Response after 6 Months of Highly Active Antiretroviral Therapy Sophie Grabar , Vincent Le Moing , Cécile Goujard , Catherine Leport , Michel D. Kazatchkine , Dominique Costagliola , and Laurence Weiss Metrics 19 September 2000Volume 133, Issue 6Page: I-16KeywordsDrug therapyDrugsHIV infectionsHIV-1Hematologic testsHighly active antiretroviral therapyLaboratory testsViral load ePublished: 19 September 2000 Issue Published: 19 September 2000 Copyright & PermissionsCopyright © 2000 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
PROGNOSTIC CORRELATION OF CELL-OF-ORIGIN AND MYC, BCL-2 AND BCL-6 STATUS IN HIV-ASSOCIATED DIFFUSE LARGE B-CELL LYMPHOMAS
Authors: L. Crucitti, C. Rusconi, A. Re, L. Bandiera, M. Spina, G. Gini, M. Paulli, M. Lucioni, F. Facchetti, G. Goteri, V. Canzonieri, L. Lorenzi, P. Balzarini, S. Fisogni, R. Riboni, A. Malfitano, M. Bonfichi, M. C. Moioli, M. Nichelatti, F. Melle, G. Motta, S. A. Pileri, R. Cairoli
Journal: HemaSphere (2019)
Markers of DNA Repair and Susceptibility to Cancer in Humans: an Epidemiologic Review
Authors: M. Berwick
Journal: JNCI Journal of the National Cancer Institute (2000)

DNA repair is a system of defenses designed to protect the integrity of the genome. Deficiencies in this system likely lead to the development of cancer. The epidemiology of DNA repair capacity and of its effect on cancer susceptibility in humans is, therefore, an important area of investigation. We have summarized all of the published epidemiologic studies on DNA repair in human cancer through 1998 (n = 64) that addressed the association of cancer susceptibility with a putative defect in DNA repair capacity. We have considered study design, subject characteristics, potential biases, confounding variables, and sources of technical variability. Assays of DNA repair capacity used, to date, can be broadly grouped into five categories: 1) tests based on DNA damage induced with chemicals or physical agents, such as the mutagen sensitivity assay, the G2-radiation assay, induced micronuclei, and the Comet assay; 2) indirect tests of DNA repair, such as unscheduled DNA synthesis; 3) tests based on more direct measures of repair kinetics, such as the host cell reactivation assay; 4) measures of genetic variation associated with DNA repair; and 5) combinations of more than one category of assay. The use of such tests in human populations yielded positive and consistent associations between DNA repair capacity and cancer occurrence (with odds ratios in the range of 1.4–75.3, with the majority of values between 2 and 10). However, the studies that we have reviewed have limitations, including small sample size, “convenience” controls, the use of cells different from the target organ, and the use of mutagens that do not occur in the natural environment. The evolving ability to study polymorphisms in DNA repair genes may contribute to new understandings about the mechanisms of DNA repair and the way in which DNA repair capacity affects the development of cancer.